Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4

Plus Therapeutics (PSTV) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.67 per share a year ago.